Statistics from Altmetric.com
By Josh Loeb
More pharmaceutical companies have gone public with their predictions that the supply of veterinary medicines will carry on as normal under any form of Brexit, including a no-deal Brexit, amid continuing uncertainty over the eventual outcome.
MSD Animal Health said it was ‘confident that our contingency plans across our business have been implemented effectively and will help to ensure that MSD’s supply will not be negatively impacted as a consequence of Brexit.’
Vet Mark Leddy, UK country manager for veterinary company TVM, also said he did not anticipate shortages.
We’re confident of supply at this point in time and don’t have any particular concerns for the foreseeable future
‘We’re confident of supply at this point in time and don’t have any particular concerns for the foreseeable future,’ Leddy told Vet Record.
Meanwhile Boehringer Ingelheim said it had procured additional warehouse space in the UK …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.